<DOC>
	<DOCNO>NCT01269606</DOCNO>
	<brief_summary>This trial conduct Japan . The aim trial compare pharmacokinetics ( rate body eliminate substance body ) insulin aspart fast-acting insulin human follow intravenous ( IV ) infusion intramuscular ( IM ) injection Japanese subject type 1 diabetes mellitus .</brief_summary>
	<brief_title>Comparing Insulin Aspart With Fast-acting Insulin Human Subjects With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Type 1 diabetes mellitus ( diagnose clinically ) least 12 month Treated multiple daily insulin injection least 12 month Current daily basal insulin requirement equal 0.3 U/kg/day Glycosylated haemoglobin A1c ( HbA1c ) equal 10.0 % Body Mass Index ( BMI ) 18.028.0 kg/m^2 Subject donate blood plasma past month 500 mL within 3 month prior trial start ( screen ) Surgery trauma significant blood loss ( 500 mL ) within 3 month prior trial start ( screen ) Subject smoke 10 cigarette equivalent per day Not able willing refrain smoking use nicotine gum transdermal nicotine patch inpatient period</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>